OrthoPediatrics Corp.

Fundamentals5.0
Price Action6.0
News Sentiment7.0
AI Rating
6.0

Key Drivers

  • Improving Profitability
  • High Net Debt
  • Inventory Concentration

AI
AI Summary

6.0

KIDS is becoming a more diversified growth platform, but the investment thesis remains unproven until Trauma & Deformity and other businesses offset scoliosis weakness and convert improving EBITDA into positive free cash flow, making the stock's sharp rally vulnerable to execution or cash-flow disappointments.

GrowthOpportunity
CashFlowRisk
Valuation‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

5.0

Key Financial Insights:

  • Improving Profitability
  • High Net Debt
  • Inventory Concentration

Quarterly profitability and cash flow improved meaningfully, but persistent losses, negative free cash flow, high inventory, and substantial net debt remain key risks.

OperationalImprovement
CashFlowRisk

Price Behavior

6.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Strong Uptrend
  • Elevated Momentum
  • Pullback Risk

KIDS remains strongly bullish after a 36% rise over the last month, but its RSI near 86 and rejection below $26.50 suggest elevated pullback risk, with $24.70 support critical to maintaining momentum.

Bullish
Overbought
Support Level: $24.70–$24.80; secondary $22.77–$23.28
Resistance Level: $26.50

KIDS surged approximately 36% over the last month, accelerating sharply after

Sentiment & News

7.0

Key News Insights:

  • Record Revenue
  • Guidance Raised
  • Product Momentum

OrthoPediatrics delivered record Q2 revenue, beat loss expectations, raised 2026 revenue guidance, and highlighted accelerating growth from newer products.

Growth
Guidance

Positive results and increased revenue guidance could support investor sentiment toward KIDS